Sol Strategies just dropped some news that’s got people talking about Solana again.
This Canadian company has filed to list on the Nasdaq under the ticker STKE, and it’s currently holding over 420,000 SOL, worth around $61 million.
But while everyone’s watching this institutional play unfold, there’s another project called Solaxy that could benefit from being Solana’s first Layer-2 solution.
Sol Strategies Nasdaq Filing – A Detailed Overview
Sol Strategies is the only publicly traded company in North America that’s all-in on Solana.
The company began as Cypherpunk Holdings in 2002, then did a complete rebrand and pivoted to Solana in September 2024.
They filed the Nasdaq paperwork with the SEC yesterday to get listed on the exchange as “STKE.”
Right now, they trade in Canada as “HODL,” but they want access to the big leagues.
That means American investors with much deeper pockets.
Sol Strategies’ stock popped 4% after the announcement, closing at CAD 2.38.
Most of the excitement around the company is because it runs validator nodes, stakes SOL, and builds Solana infrastructure.
Plus, Sol Strategies raised $500 million specifically to buy more SOL, and filed for another $1 billion shelf in Canada.
They even want to tokenize their company shares on Solana.
That’s the kind of ambition that shows Sol Strategies is serious about transforming how finance works in 2025.
SOL Price Prediction – Can Solana Rally to $200 Soon?
Now let’s talk about Solana itself.
It’s trading around $145, down 8% this week and 12% over the past month.
Spot trading volumes are lighter, and open interest has dropped over the last three days.
But this looks more like consolidation than anything disastrous.
Reaching $200 from here means SOL needs to climb about 37%, which isn’t a huge stretch given what might be coming.
The big catalyst everyone’s waiting for is the spot Solana ETF – Bloomberg analysts are saying there’s a 90% chance it gets approved in July 2025.
Then there’s Firedancer, which is expected to roll out this year.
This upgrade will double Solana’s transaction capacity and resolve the congestion issues that pop up when things get busy.
When your network can handle twice as many transactions without breaking a sweat, that’s usually good for your token’s price.
And institutions are already positioning themselves.
DeFi Development Corporation recently locked in $5 billion for the sole purpose of buying SOL.
So, although things might look bleak for SOL right now, there’s a real chance it could rebound to $200 by the time summer is over.
New Layer-2 Play Solaxy Could Benefit from SOL’s Rise After Raising $54M in Presale
One new project that could benefit from all this is Solaxy.
But why does Sol Strategies’ Nasdaq filing matter for the SOLX price?
It’s simple – when the only major public company focused on Solana gets the green light in American markets, it validates the whole ecosystem.
Suddenly, institutional investors who wouldn’t touch SOL start looking at Solana-linked infrastructure plays in a different light.
Plus, when the SOL price pumps, network activity usually explodes too.
That’s exactly when you need a Layer-2 solution to handle the extra traffic without everything grinding to a halt.
Solaxy processes transactions off-chain first, then settles them back to the main network, keeping things smooth when everyone is trying to trade at once.
The token rewards are a big draw, too.
Solaxy’s team is offering staking rewards of 77% APY, and investors have already pledged over 14.9 billion SOLX tokens.
Plus, they’re building a bridge between Solana and Ethereum, which 99Bitcoins’ analysts predict could be huge for institutional liquidity.
Lastly, when SOL rallies, Solana ecosystem tokens tend to surge as well.
For example, Moo Deng shot up 992% in early May when Solana was bullish.
Solaxy’s massive presale success puts SOLX in a position to catch that same momentum when it goes live.
Ultimately, if Sol Strategies gets its Nasdaq approval around the same time SOL pushes toward $200, you’re looking at two major catalysts hitting at once for Solaxy.